The article "Do we need still more trials on T4 and T3 combination therapy in hypothyroidism?" (European Journal of Endocrinology, 2009, PMID: 19808902) discusses the ongoing debate surrounding the use of levothyroxine (T4) and liothyronine (T3) combination therapy in managing hypothyroidism. While some patients report improved well-being with combination therapy,
